Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | Pomoč | SLO | ENG

Naslov:Retinoblastoma with and without extraocular tumor extension : a global comparative study of 3435 patients
Avtorji:ID Kaliki, Swathi (Avtor)
ID Vempuluru, Vijitha S. (Avtor)
ID Fabian, Ido Didi (Avtor)
ID Lavrič Groznik, Alenka (Sodelavec pri raziskavi)
ID Tekavčič Pompe, Manca (Sodelavec pri raziskavi), et al.
Datoteke:.pdf PDF - Predstavitvena datoteka, prenos (508,94 KB)
MD5: 0E2454203BDEDAFC08B119F605F79664
 
URL URL - Izvorni URL, za dostop obiščite https://doi.org/10.1016/j.xops.2024.100637
 
Jezik:Angleški jezik
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:Logo UKC LJ - Univerzitetni klinični center Ljubljana
Povzetek:Purpose To study the treatment and outcomes of children with retinoblastoma (RB) with extraocular tumor extension (RB-EOE) and compare them with RB without extraocular tumor extension (RB-w/o-EOE). Design Multicenter intercontinental collaborative prospective study from 2017 to 2020. RB-EOE cases included those with overt orbital tumor extension in treatment-naive patients. Cases with microscopic orbital extension detected postenucleation were excluded from the study. Participants A total of 319 children with RB-EOE and 3116 children with RB-w/o-EOE. Intervention Chemotherapy, enucleation, exenteration, radiotherapy. Main Outcome Measures Systemic metastasis and death. Results Of the 3435 RB patients included in this study, 309 (9%) were from low-income countries (LIC), 1448 (42%) from lower-middle income, 1012 (29%) from upper-middle income, and 666 (19%) patients from high-income countries. There was an inverse relationship between the percentage of RB-EOE and national income level, with 96 (31%) patients from LIC, 197 (6%) lower-middle income, 20 (2%) upper-middle income, and 6 (1%) patients from high-income countries (P = 0.0001). The outcomes were statistically significant for RB-EOE compared with RB-w/o-EOE: systemic metastasis (32% vs. 4% respectively; P = 0.0001) and metastasis-related death (63% vs. 6% respectively; P = 0.0001). Multimodal treatment was the most common form of treatment (n = 177; 54%) for RB-EOE, with most cases undergoing a combination of intravenous chemotherapy and enucleation (n = 97; 30%). Adjuvant external beam radiotherapy (EBRT) after surgery (enucleation/orbital exenteration) was given in only 68 (21%) cases. Kaplan–Meier analysis for systemic metastasis and metastasis-related death in RB-EOE was 28% and 57% at 1 year, 29% and 60% at 2 years, and 29% and 61% at 3 years, respectively. Cox regression analysis revealed that the risk of death from RB-EOE was greater in patients aged >4 years than <2 years (hazard ratio, 2.912; P < 0.001) and for unimodal (surgery or intravenous chemotherapy) and bimodal (surgery and intravenous chemotherapy) treatment than trimodal treatment (surgery, intravenous chemotherapy, and EBRT) (hazard ratio, 2.023; P = 0.004 and hazard ratio, 1.819; P = 0.027, respectively). Conclusions Retinoblastoma with extraocular tumor extension is associated with a higher risk of metastasis and death. Patients with RB-EOE are likely to benefit from trimodal treatment (intravenous chemotherapy, surgery, and EBRT) rather than treatment protocols excluding EBRT.
Ključne besede:external beam radiotherapy, extraocular extension, multimodal treatment, retinoblastoma, tumor
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Leto izida:2025
Št. strani:str. 1-8
Številčenje:Vol. 5, issue 2, [article no.] 100637
PID:20.500.12556/DiRROS-28105 Novo okno
UDK:617.7
ISSN pri članku:2666-9145
DOI:10.1016/j.xops.2024.100637 Novo okno
COBISS.SI-ID:240654851 Novo okno
Opomba:Nasl. z nasl. zaslona; Opis vira z dne 27. 6. 2025;
Datum objave v DiRROS:10.03.2026
Število ogledov:72
Število prenosov:27
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
  
Objavi na:Bookmark and Share


Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:Ophthalmology science
Založnik:Elsevier, Inc.
ISSN:2666-9145
COBISS.SI-ID:68442883 Novo okno

Licence

Licenca:CC BY-NC-ND 4.0, Creative Commons Priznanje avtorstva-Nekomercialno-Brez predelav 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by-nc-nd/4.0/deed.sl
Opis:Najbolj omejujoča licenca Creative Commons. Uporabniki lahko prenesejo in delijo delo v nekomercialne namene in ga ne smejo uporabiti za nobene druge namene.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:obsevanje z zunanjim žarkom, zunajočesna ekstenzija, multimodalno zdravljenje, retinoblastom, tumor


Nazaj